PRX302: Clinical Trials

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	5	Completed 5
Phase 1	1	Completed 1

Follow PRX302: new trials by email Literature Review of PRX302 trials Research Report on PRX302

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer PRX302 - Prostate Cancer	Phase 2	Completed	Sophiris Bio Corp	38	2017-06-07	2019-04-10
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer PRX302 - Prostate Cancer	Phase 2	Completed	Sophiris Bio Corp	18	2015-07-01	2016-07-27
Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) PRX302, Placebo - Benign Prostatic Hyperplasia	Phase 1 / Phase 2	Completed	Sophiris Bio Corp	40	2011-09-01	2013-08-21
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic Hyperplasia PRX302, Placebo - Benign Prostatic Hyperplasia	Phase 2	Completed	Sophiris Bio Corp	92	2009-01-01	2018-11-21
An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of Patients With Locally Recurrent Prostate Cancer After Primary Radiation Therapy PRX302 - Locally Recurrent Prostate Cancer	Phase 2	Completed	Sophiris Bio Corp	30	2008-02-01	2009-10-29

Conditions studied

Prostatic Neoplasms (3)  ·  Prostatic Hyperplasia (2)  ·  Lower Urinary Tract Symptoms (1)

Sponsors

Sophiris Bio Corp (5)

Countries

United States (3)  ·  United Kingdom (2)  ·  Canada (1)

Top investigators

Hashim U Ahmed, MD (1)  ·  Hashim U Ahmed, PhD,FRCS (1)  ·  Mostafa Elhilali, MD (1)  ·  Peter Pommerville, MD (1)  ·  Richard C. Yocum, MD (1)